PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33716662-3	2021	Changes in these signaling pathways would control phosphorylation of transcription factors cAMP response-element binding protein (CREB), forkhead box01 (FoxO1), and brain homeobox transcription factor (BSX) leading to food intake inhibition through changes in the expression of neuropeptide Y (NPY), agouti-related peptide (AgRP), pro-opio melanocortin (POMC), and cocaine and amphetamine-related transcript (CART).	Amphetamine	377-388	neuropeptide Y	Homo sapiens	278-292	
33716662-3	2021	Changes in these signaling pathways would control phosphorylation of transcription factors cAMP response-element binding protein (CREB), forkhead box01 (FoxO1), and brain homeobox transcription factor (BSX) leading to food intake inhibition through changes in the expression of neuropeptide Y (NPY), agouti-related peptide (AgRP), pro-opio melanocortin (POMC), and cocaine and amphetamine-related transcript (CART).	Amphetamine	377-388	neuropeptide Y	Homo sapiens	294-297	
15604214-3	2005	We found that NPY-SAP profoundly reduced NPY Y1 receptor and alpha MSH immunoreactivity, as well as NPY, Agouti gene-related protein (AGRP), and cocaine and amphetamine-related transcript mRNA expression in the BMH.	Amphetamine	157-168	neuropeptide Y	Homo sapiens	14-17	
25904345-3	2016	We report on the effects of psychostimulants [cocaine, amphetamine, methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and nicotine], ethanol, and opioids on NPY protein levels and expression of different NPY receptors.	Amphetamine	55-66	neuropeptide Y	Homo sapiens	165-168	
16210367-1	2006	The reductions in circulating levels of leptin, insulin, and glucose with fasting serve as important homeostasis signals to neurons of the hypothalamic arcuate nucleus that synthesize neuropeptide Y (NPY)/agouti-related protein (AGRP) and alpha-MSH/cocaine and amphetamine-regulated transcript.	Amphetamine	261-272	neuropeptide Y	Homo sapiens	184-198	
16210367-1	2006	The reductions in circulating levels of leptin, insulin, and glucose with fasting serve as important homeostasis signals to neurons of the hypothalamic arcuate nucleus that synthesize neuropeptide Y (NPY)/agouti-related protein (AGRP) and alpha-MSH/cocaine and amphetamine-regulated transcript.	Amphetamine	261-272	neuropeptide Y	Homo sapiens	200-203	
14659580-0	2003	Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression.	Amphetamine	117-128	neuropeptide Y	Homo sapiens	93-107	
14659580-0	2003	Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression.	Amphetamine	117-128	neuropeptide Y	Homo sapiens	109-112	
14659580-8	2003	Taken together, the present results confirmed that both subtypes of D1 and D2 receptors and cerebral NPY were involved in the anorectic action of AMPH.	Amphetamine	146-150	neuropeptide Y	Homo sapiens	101-104	
12005258-0	2001	Role of hypothalamic neuropeptide Y (NPY) in the change of feeding behavior induced by repeated treatment of amphetamine.	Amphetamine	109-120	neuropeptide Y	Homo sapiens	21-35	
12005258-0	2001	Role of hypothalamic neuropeptide Y (NPY) in the change of feeding behavior induced by repeated treatment of amphetamine.	Amphetamine	109-120	neuropeptide Y	Homo sapiens	37-40	
12005258-3	2001	In an attempt to know the role of hypothalamic NPY in these effects of AMPH, contents of hypothalamic NPY were determined by radioimmunoassay at first.	Amphetamine	71-75	neuropeptide Y	Homo sapiens	47-50	
12005258-4	2001	In AMPH-treated groups, the contents of hypothalamic NPY decreased rapidly on day 1 but restored gradually to the normal level on the following days as observed in repeated AMPH.	Amphetamine	3-7	neuropeptide Y	Homo sapiens	53-56	
12005258-4	2001	In AMPH-treated groups, the contents of hypothalamic NPY decreased rapidly on day 1 but restored gradually to the normal level on the following days as observed in repeated AMPH.	Amphetamine	173-177	neuropeptide Y	Homo sapiens	53-56	
12005258-5	2001	An involvement of hypothalamic NPY in the feeding change of repeated AMPH can thus be considered.	Amphetamine	69-73	neuropeptide Y	Homo sapiens	31-34	
12005258-7	2001	to inhibit the gene expression of hypothalamic NPY were performed at 1 hour before daily 2 mg/kg AMPH.	Amphetamine	97-101	neuropeptide Y	Homo sapiens	47-50	
12005258-9	2001	It is suggested that hypothalamic NPY may play a role in the change of feeding behavior induced by repeated AMPH administration.	Amphetamine	108-112	neuropeptide Y	Homo sapiens	34-37	
11035216-7	2000	The extent of the CPPs produced by NPY injection in both brain sites mirrored that produced by peripheral injection of amphetamine (2.5 mg/kg).	Amphetamine	119-130	neuropeptide Y	Homo sapiens	35-38